North America Induced Pluripotent Stem Cells Market Size, Share, and Growth Forecast, 2025 - 2032

North America Induced Pluripotent Stem Cells Market By Product Type (Instruments/Devices, Reagents & Kits, Services), Cell Type (Autologous, Allogeneic), Application (Drug Development, Regenerative Medicine, Others), by End-user, and Country Analysis from 2025 - 2032

Market Growth and Regional Outlook Report by Persistence Market Research

PMRREP35635
19 Sep 2025 Healthcare
175 Pages

Table of Content

  1. Executive Summary
    1. North America Induced Pluripotent Stem Cells Market Snapshot, 2025 and 2032
    2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
    3. COVID-19 Impact Analysis
    4. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Value Chain Analysis
    2. Product Adoption/Usage Analysis
    3. List of iPSC Equipment Manufacturer
    4. List of End-users for iPSC Products & Services
    5. List of Companies offering iPSC Products & Services
    6. Key Promotional Strategies, By Key Players
    7. Regulatory Landscape
    8. PESTLE Analysis
    9. Porter’s Five Force Analysis
  4. North America Induced Pluripotent Stem Cells Market Outlook
    1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019-2024
      2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
    3. North America Induced Pluripotent Stem Cells Market Outlook: Product Type
      1. Historical Market Size (US$ Mn) Analysis, By Product Type, 2019-2024
      2. Market Size (US$ Mn) and Forecast Analysis, By Product Type, 2025-2032
        1. Instruments/Devices
        2. Reagents & Kits
        3. Services
      3. Market Attractiveness Analysis: Product Type
    4. North America Induced Pluripotent Stem Cells Market Outlook: Cell Type
      1. Historical Market Size (US$ Mn) Analysis, By Cell Type, 2019-2024
      2. Market Size (US$ Mn) and Forecast Analysis, By Cell Type, 2025-2032
        1. Autologous
        2. Allogeneic
      3. Market Attractiveness Analysis: Cell Type
    5. North America Induced Pluripotent Stem Cells Market Outlook: Application
      1. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2024
      2. Market Size (US$ Mn) and Forecast Analysis, By Application, 2025-2032
        1. Drug Development
        2. Regenerative Medicine
        3. Toxicity Testing
        4. Others
      3. Market Attractiveness Analysis: Application
    6. North America Induced Pluripotent Stem Cells Market Outlook: End-user
      1. Historical Market Size (US$ Mn) Analysis, By End-user, 2019-2024
      2. Market Size (US$ Mn) and Forecast Analysis, By End-user, 2025-2032
        1. Biotechnology and Pharma Companies
        2. Academic and Research Institutes
        3. Hospitals & Clinics
        4. Cell Banks
        5. Contract Research Organizations (CROs)
      3. Market Attractiveness Analysis: End-user
  5. North America Induced Pluripotent Stem Cells Market Outlook: Country
    1. Historical Market Size (US$ Mn) Analysis, By Country, 2019-2024
    2. Market Size (US$ Mn) and Forecast Analysis, by Country, 2025-2032
      1. U.S.
      2. Canada
    3. Market Attractiveness Analysis: Country
  6. U.S. Induced Pluripotent Stem Cells Market Outlook
    1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Product Type
      2. By Cell Type
      3. By Application
      4. By End-user
    2. Market Size (US$ Mn) and Forecast Analysis, by Product Type, 2025-2032
      1. Instruments/Devices
      2. Reagents & Kits
      3. Services
    3. Market Size (US$ Mn) Analysis and Forecast, By Cell Type, 2025-2032
      1. Autologous
      2. Allogeneic
    4. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
      1. Drug Development
      2. Regenerative Medicine
      3. Toxicity Testing
      4. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
      1. Biotechnology and Pharma Companies
      2. Academic and Research Institutes
      3. Hospitals & Clinics
      4. Cell Banks
      5. Contract Research Organizations (CROs)
    6. Market Attractiveness Analysis
  7. Canada Induced Pluripotent Stem Cells Market Outlook
    1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
      1. By Product Type
      2. By Cell Type
      3. By Application
      4. By End-user
    2. Market Size (US$ Mn) and Forecast Analysis, by Product Type, 2025-2032
      1. Instruments/Devices
      2. Reagent & Kits
      3. Services
    3. Market Size (US$ Mn) Analysis and Forecast, By Cell Type, 2025-2032
      1. Autologous
      2. Allogeneic
    4. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
      1. Drug Development
      2. Regenerative Medicine
      3. Toxicity Testing
      4. Others
    5. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
      1. Biotechnology and Pharma Companies
      2. Academic and Research Institutes
      3. Hospitals & Clinics
      4. Cell Banks
      5. Contract Research Organizations (CROs)
    6. Market Attractiveness Analysis
  8. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
      1. Competition Intensity Mapping by Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. FUJIFILM Holdings Corporation (Cellular Dynamics)
        1. Overview
        2. Segments and Applications
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Thermo Fisher Scientific, Inc.
      3. Hitachi Ltd.
      4. Lonza
      5. Terumo Corporation
      6. Miltenyi Biotec
      7. Takara Bio Inc
      8. Sartorius AG
      9. Merck KGaA
      10. Horizon Discovery Group plc.
      11. Cell Applications, Inc.
      12. Others
  9. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate